127 related articles for article (PubMed ID: 12852764)
1. Synthesis and in vitro characterization of 1-(4-aminofurazan-3-yl)-5-dialkylaminomethyl-1H-[1,2,3]triazole-4-carboxylic acid derivatives. A new class of selective GSK-3 inhibitors.
Olesen PH; Sørensen AR; Ursø B; Kurtzhals P; Bowler AN; Ehrbar U; Hansen BF
J Med Chem; 2003 Jul; 46(15):3333-41. PubMed ID: 12852764
[TBL] [Abstract][Full Text] [Related]
2. Design, synthesis, and urease inhibition studies of some 1,3,4-oxadiazoles and 1,2,4-triazoles derived from mandelic acid.
Akhtar T; Hameed S; Khan KM; Khan A; Choudhary MI
J Enzyme Inhib Med Chem; 2010 Aug; 25(4):572-6. PubMed ID: 20235688
[TBL] [Abstract][Full Text] [Related]
3. Oxidative stress-induced insulin resistance in rat skeletal muscle: role of glycogen synthase kinase-3.
Dokken BB; Saengsirisuwan V; Kim JS; Teachey MK; Henriksen EJ
Am J Physiol Endocrinol Metab; 2008 Mar; 294(3):E615-21. PubMed ID: 18089761
[TBL] [Abstract][Full Text] [Related]
4. N-Phenyl-4-pyrazolo[1,5-b]pyridazin-3-ylpyrimidin-2-amines as potent and selective inhibitors of glycogen synthase kinase 3 with good cellular efficacy.
Tavares FX; Boucheron JA; Dickerson SH; Griffin RJ; Preugschat F; Thomson SA; Wang TY; Zhou HQ
J Med Chem; 2004 Sep; 47(19):4716-30. PubMed ID: 15341487
[TBL] [Abstract][Full Text] [Related]
5. Rapid antidepressive-like activity of specific glycogen synthase kinase-3 inhibitor and its effect on beta-catenin in mouse hippocampus.
Kaidanovich-Beilin O; Milman A; Weizman A; Pick CG; Eldar-Finkelman H
Biol Psychiatry; 2004 Apr; 55(8):781-4. PubMed ID: 15050857
[TBL] [Abstract][Full Text] [Related]
6. Novel GSK-3 inhibitors with improved cellular activity.
Peat AJ; Garrido D; Boucheron JA; Schweiker SL; Dickerson SH; Wilson JR; Wang TY; Thomson SA
Bioorg Med Chem Lett; 2004 May; 14(9):2127-30. PubMed ID: 15080993
[TBL] [Abstract][Full Text] [Related]
7. The novel imidazopyridine 2-[2-(4-methoxy-pyridin-2-yl)-ethyl]-3H-imidazo[4,5-b]pyridine (BYK191023) is a highly selective inhibitor of the inducible nitric-oxide synthase.
Strub A; Ulrich WR; Hesslinger C; Eltze M; Fuchss T; Strassner J; Strand S; Lehner MD; Boer R
Mol Pharmacol; 2006 Jan; 69(1):328-37. PubMed ID: 16223957
[TBL] [Abstract][Full Text] [Related]
8. Synthesis of oleanolic acid dimers as inhibitors of glycogen phosphorylase.
Cheng K; Liu J; Sun H; Xie J
Chem Biodivers; 2010 Mar; 7(3):690-7. PubMed ID: 20232331
[TBL] [Abstract][Full Text] [Related]
9. Design, synthesis and structure-activity relationships of 1,3,4-oxadiazole derivatives as novel inhibitors of glycogen synthase kinase-3beta.
Saitoh M; Kunitomo J; Kimura E; Hayase Y; Kobayashi H; Uchiyama N; Kawamoto T; Tanaka T; Mol CD; Dougan DR; Textor GS; Snell GP; Itoh F
Bioorg Med Chem; 2009 Mar; 17(5):2017-29. PubMed ID: 19200745
[TBL] [Abstract][Full Text] [Related]
10. Synthesis and evaluation of 8-amino-[1,2,4]triazolo[4,3-a]pyridin-3(2H)-one derivatives as glycogen synthase kinase-3 (GSK-3) inhibitors.
Chun K; Park JS; Lee HC; Kim YH; Ye IH; Kim KJ; Ku IW; Noh MY; Cho GW; Kim H; Kim SH; Kim J
Bioorg Med Chem Lett; 2013 Jul; 23(13):3983-7. PubMed ID: 23683591
[TBL] [Abstract][Full Text] [Related]
11. Chronic selective glycogen synthase kinase-3 inhibition enhances glucose disposal and muscle insulin action in prediabetic obese Zucker rats.
Dokken BB; Henriksen EJ
Am J Physiol Endocrinol Metab; 2006 Aug; 291(2):E207-13. PubMed ID: 16478771
[TBL] [Abstract][Full Text] [Related]
12. Synthesis and discovery of macrocyclic polyoxygenated bis-7-azaindolylmaleimides as a novel series of potent and highly selective glycogen synthase kinase-3beta inhibitors.
Kuo GH; Prouty C; DeAngelis A; Shen L; O'Neill DJ; Shah C; Connolly PJ; Murray WV; Conway BR; Cheung P; Westover L; Xu JZ; Look RA; Demarest KT; Emanuel S; Middleton SA; Jolliffe L; Beavers MP; Chen X
J Med Chem; 2003 Sep; 46(19):4021-31. PubMed ID: 12954055
[TBL] [Abstract][Full Text] [Related]
13. Identification of glycogen synthase kinase-3 inhibitors with a selective sting for glycogen synthase kinase-3α.
Lo Monte F; Kramer T; Gu J; Anumala UR; Marinelli L; La Pietra V; Novellino E; Franco B; Demedts D; Van Leuven F; Fuertes A; Dominguez JM; Plotkin B; Eldar-Finkelman H; Schmidt B
J Med Chem; 2012 May; 55(9):4407-24. PubMed ID: 22533818
[TBL] [Abstract][Full Text] [Related]
14. Antipsychotics alter the protein expression levels of beta-catenin and GSK-3 in the rat medial prefrontal cortex and striatum.
Alimohamad H; Rajakumar N; Seah YH; Rushlow W
Biol Psychiatry; 2005 Mar; 57(5):533-42. PubMed ID: 15737669
[TBL] [Abstract][Full Text] [Related]
15. Organometallic compounds with biological activity: a very selective and highly potent cellular inhibitor for glycogen synthase kinase 3.
Atilla-Gokcumen GE; Williams DS; Bregman H; Pagano N; Meggers E
Chembiochem; 2006 Sep; 7(9):1443-50. PubMed ID: 16858717
[TBL] [Abstract][Full Text] [Related]
16. Structure-based design and subsequent optimization of 2-tolyl-(1,2,3-triazol-1-yl-4-carboxamide) inhibitors of p38 MAP kinase.
Cogan DA; Aungst R; Breinlinger EC; Fadra T; Goldberg DR; Hao MH; Kroe R; Moss N; Pargellis C; Qian KC; Swinamer AD
Bioorg Med Chem Lett; 2008 Jun; 18(11):3251-5. PubMed ID: 18462940
[TBL] [Abstract][Full Text] [Related]
17. The interaction of glycogen synthase kinase-3 (GSK-3) with the cell cycle.
Ryves WJ; Harwood AJ
Prog Cell Cycle Res; 2003; 5():489-95. PubMed ID: 14593744
[TBL] [Abstract][Full Text] [Related]
18. Structural basis for the GSK-3beta binding affinity and selectivity against CDK-2 of 1-(4-aminofurazan-3yl)-5-dialkylaminomethyl-1H-[1,2,3] triazole-4-carboxylic acid derivatives.
Pande V; Ramos MJ
Bioorg Med Chem Lett; 2005 Dec; 15(23):5129-35. PubMed ID: 16213715
[TBL] [Abstract][Full Text] [Related]
19. 9-cyano-1-azapaullone (cazpaullone), a glycogen synthase kinase-3 (GSK-3) inhibitor activating pancreatic beta cell protection and replication.
Stukenbrock H; Mussmann R; Geese M; Ferandin Y; Lozach O; Lemcke T; Kegel S; Lomow A; Burk U; Dohrmann C; Meijer L; Austen M; Kunick C
J Med Chem; 2008 Apr; 51(7):2196-207. PubMed ID: 18345612
[TBL] [Abstract][Full Text] [Related]
20. Unlike insulin, amino acids stimulate p70S6K but not GSK-3 or glycogen synthase in human skeletal muscle.
Liu Z; Wu Y; Nicklas EW; Jahn LA; Price WJ; Barrett EJ
Am J Physiol Endocrinol Metab; 2004 Apr; 286(4):E523-8. PubMed ID: 14656717
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
